MGLL-IN-Cpd118
General
Type : Triazol, Azaspiro, Trifluoro, Pyrazole
Chemical_Nomenclature : [6-(3-cyclopropyl-1,2,4-triazol-1-yl)-2-azaspiro[3.3]heptan-2-yl]-[6-[[5-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-2-azaspiro[3.3]heptan-2-yl]methanone
Canonical SMILES : C1CC1C2=NN(C=N2)C3CC4(C3)CN(C4)C(=O)N5CC6(C5)CC(C6)CC7=C(NN=C7)C(F)(F)F
InChI : InChI=1S\/C23H28F3N7O\/c24-23(25,26)18-16(8-28-29-18)3-14-4-21(5-14)9-31(10-21)20(34)32-11-22(12-32)6-17(7-22)33-13-27-19(30-33)15-1-2-15\/h8,13-15,17H,1-7,9-12H2,(H,28,29)
InChIKey : PFFZCLKOQQPASJ-UHFFFAOYSA-N
Other name(s) : Compound 118 || Cpd118
MW : 475.5
Formula : C23H28F3N7O
CAS_number :
PubChem : 171533014
UniChem : PFFZCLKOQQPASJ-UHFFFAOYSA-N
Target
Families : MGLL-IN-Cpd118 ligand of proteins in family
Monoglyceridelipase_lysophospholip
Protein :
human-MGLL
References (1)
| Title : Novel Heterocyclic Compounds as Monoacylglycerol Lipase Inhibitors for Treating Multiple Diseases - Sabnis_2024_ACS.Med.Chem.Lett_15_994 |
| Author(s) : Sabnis RW |
| Ref : ACS Med Chem Lett , 15 :994 , 2024 |
| Abstract : |
| PubMedSearch : Sabnis_2024_ACS.Med.Chem.Lett_15_994 |
| PubMedID: 39015277 |